| C/P | Industry | Status | Ticker(s) | Issuer(s) | Size(m) | Tranches | Region | Date | |
|---|---|---|---|---|---|---|---|---|---|
IGC | HLTH | PRCD | BSX | American Medical Systems Europe BV | €4,250 | 6 | USOA | Nov 19, 2026 |
2yr (Dec 2029) @ 3mE+85-90
Implied Spread for fresh 2yr @ 3mE+55
Priced at 3mE+63
NIC of +8
2yr (Dec 2028) @ MS+75-80
Implied Spread for fresh 2yr @ MS+45
Priced at MS+53
NIC of +8
4yr (Dec 2030) @ MS+105a
Implied Spread for fresh 4yr @ MS+70
Priced at MS+75
NIC of +5
8yr (Dec 2034) @ MS+135-140
Implied Spread for fresh 8yr @ MS+105
Priced at MS+110
NIC of +5
12yr (Dec 2038) @ MS+160-165
Implied Spread for fresh 12yr @ MS+125
Priced at MS+135
NIC of +10
20yr (Dec 2046) @ MS+200a
Implied Spread for fresh 20yr @ MS+160
Priced at MS+170
NIC of +10
COMPS | |||||
A Rated Med-Tech | |||||
Bond | Rating (M/S&P/F) | Issue Dt. | Amt | Tenor | I-spread |
BSX 1.375 3/28 | A3 / A- / A- | Mar-22 | €750mm | 1.3yr | ms+38bp |
BSX 3.375 3/29 | A3 / A- / A- | Feb-24 | €750mm | 2.3yr | ms+51bp |
BSX 3.000 3/31 | A3 / A- / A- | Feb-25 | €850mm | 4.3yr | ms+70bp |
BSX 1.625 3/31 | A3 / A- / A- | Mar-22 | €750mm | 4.3yr | ms+67bp |
BSX 3.500 3/32 | A3 / A- / A- | Feb-24 | €1250mm | 5.3yr | ms+80bp |
BSX 3.250 3/34 | A3 / A- / A- | Feb-25 | €650mm | 7.3yr | ms+97bp |
BSX 1.875 3/34 | A3 / A- / A- | Mar-22 | €500mm | 7.3yr | ms+91bp |
DHR 0.750 9/31 | A2 / A- / - | Sep-19 | €1750mm | 4.8yr | ms+55bp |
DHR 3.625 4/34 | A2 / A- / - | Apr-26 | €750mm | 7.5yr | ms+78bp |
DHR 4.000 4/38 | A2 / A- / - | Apr-26 | €1000mm | 11.5yr | ms+96bp |
DHR 1.800 9/49 | A2 / A- / - | Sep-19 | €750mm | 22.9yr | ms+129bp |
MDT 3.650 10/29 | A3 / A / - | Jun-24 | €850mm | 2.9yr | ms+38bp |
MDT 2.950 10/30 | A3 / A / - | Sep-25 | €750mm | 3.9yr | ms+48bp |
MDT 3.875 10/36 | A3 / A / - | Jun-24 | €850mm | 9.9yr | ms+81bp |
MDT 4.150 10/43 | A3 / A / - | Jun-24 | €600mm | 16.9yr | ms+131bp |
MDT 4.200 10/45 | A3 / A / - | Sep-25 | €750mm | 18.9yr | ms+141bp |
SYK 3.375 9/32 | A3 / BBB+ / - | Sep-24 | €800mm | 5.8yr | ms+71bp |
SYK 3.625 9/36 | A3 / BBB+ / - | Sep-24 | €600mm | 9.8yr | ms+91bp |
TMO 3.628 12/35 | A2 / A- / A- | Dec-25 | €1100mm | 9.0yr | ms+81bp |
TMO 1.875 10/49 | A2 / A- / A- | Sep-19 | €1000mm | 22.9yr | ms+138bp |
TMO 2.000 10/51 | A2 / A- / A- | Oct-21 | €750mm | 24.9yr | ms+137bp |
Other Recent Healthcare | |||||
Bond | Rating (M/S&P/F) | Issue Dt. | Amt | Tenor | I-spread |
GSK 3.500 9/30 | A2 / A / - | Sep-26 | €1000mm | 3.8yr | ms+51bp |
GSK 3.875 9/34 | A2 / A / - | Sep-26 | €850mm | 7.8yr | ms+76bp |
GSK 4.125 9/37 | A2 / A / - | Sep-26 | €800mm | 10.8yr | ms+96bp |
MRKGR 3.875 5/31 | A3 / A / - | Nov-26 | €900mm | 4.5yr | ms+58bp |
MRKGR 4.125 11/33 | A3 / A / - | Nov-26 | €1050mm | 7.0yr | ms+78bp |
MRKGR 4.250 11/36 | A3 / A / - | Nov-26 | €1050mm | 10.0yr | ms+97bp |
Healthcare FRNs | |||||
Bond | Rating (M/S&P/F) | Issue Dt. | Amt | Tenor | Spread |
DHR FRN 4/28 | A2 / A- / - | Apr-26 | €500mm | 1.4yr | 3mE+36bp |
GSK FRN 3/28 | A2 / A / - | Sep-26 | €850mm | 1.3yr | 3mE+31bp |
MRKGR FRN 11/28 | A3 / A / - | Nov-26 | €700mm | 2.0yr | 3mE+43bp |
TMO FRN 12/27 | A2 / A- / A- | Dec-25 | €1000mm | 1.0yr | 3mE+35bp |
| CreditFlow: End of Day (Europe IG) | 11:32 AM ET |